Industry-reported use ranges from 8% in rinse-off products and 2% in leave-on formulations
The peptides we supply are synthesized with exact amino-acid sequencing and verified purity
Research and Development: The company continues to invest in research to better understand the drugs long-term effects and possibly develop safer alternatives or modifications to existing formulations
Surgery 232 (2), 199201
People may microdose GLP-1 medications for many reasons, including: They have hit their target weight goal They have concerns about the cost of the medications They are sensitive to the side effects of the medications They want to just suppress their appetite They are worried about the supply of the medications Microdosing GLP-1 medications can come with real risks, including: Inaccurate doses Reduced effectiveness Unpredictable outcomes Possibility of regaining weight No data on the long-term effects of microdosing Minimal oversight Large clinical trials have confirmed that the standard GLP-1 doses work well when helping people lose weight and manage Type 2 diabetes
Last reviewed: July 21, 2026 Last updated: July 21, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations